Label: DG HEALTH ALLERGY RELIEF- loratadine capsule, liquid filled

  • NDC Code(s): 55910-629-39, 55910-629-52
  • Packager: Dolgencorp Inc
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated March 11, 2025

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient (in each capsule)

    Loratadine 10 mg

  • Purpose

    Antihistamine

  • Uses

    temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

    •
    runny nose
    •
    itchy, watery eyes
    •
    sneezing
    •
    itching of the nose or throat
  • Warnings

    Do not use

    if you have ever had an allergic reaction to this product or any of its ingredients.

    Ask a doctor before use if you have

    liver or kidney disease. Your doctor should determine if you need a different dose.

    When using this product

    do not take more than directed. Taking more than directed may cause drowsiness.

    Stop use and ask a doctor if

    an allergic reaction to this product occurs. Seek medical help right away.

    If pregnant or breast-feeding,

    ask a health professional before use.

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

  • Directions

    adults and children 6 years and over

    1 capsule daily; not more than 1 capsule in 24 hours

    children under 6 years of age

    ask a doctor

    consumers with liver or kidney disease

    ask a doctor
  • Other information

    •
    do not use if blister unit is broken or torn
    •
    store between 20° to 25°C (68° to 77°F)
    •
    protect from freezing
    •
    meets USP dissolution test 2
  • Inactive ingredients

    FD&C blue no.1, gelatin, glycerin, hydrolyzed collagen, hypromellose, isopropyl alcohol, mannitol, medium chain mono- & di-glycerides, propylene glycol, purified water, sorbitan, sorbitol, titanium dioxide

  • Questions or comments?

    1-888-309-9030

  • Package/Label Principal Display Panel

    DGTM | health

    Compare to the active ingredient of Claritin® Liqui-Gels®

    Original Prescription Strength

    Allergy Relief

    Loratadine Capsules, 10 mg • Antihistamine

    Indoor & Outdoor Allergies

    Non Drowsy*

    24 HOUR

    24 Hour Relief of:

    • Sneezing • Runny nose

    • Itchy, watery eyes

    • Itchy throat or nose

    10 Liquid-Filled Capsules

    10 mg

    *When taken as directed. See Drug Facts Panel.

    Actual Capsule Size

    allergy relief
  • INGREDIENTS AND APPEARANCE
    DG HEALTH ALLERGY RELIEF 
    loratadine capsule, liquid filled
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:55910-629
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LORATADINE (UNII: 7AJO3BO7QN) (LORATADINE - UNII:7AJO3BO7QN) LORATADINE10 mg
    Inactive Ingredients
    Ingredient NameStrength
    FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
    GELATIN, UNSPECIFIED (UNII: 2G86QN327L)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
    ISOPROPYL ALCOHOL (UNII: ND2M416302)  
    MANNITOL (UNII: 3OWL53L36A)  
    GLYCERYL MONO- AND DICAPRYLOCAPRATE (UNII: U72Q2I8C85)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    WATER (UNII: 059QF0KO0R)  
    SORBITAN (UNII: 6O92ICV9RU)  
    SORBITOL (UNII: 506T60A25R)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    Product Characteristics
    ColorBLUE (clear) Scoreno score
    ShapeOVALSize10mm
    FlavorImprint Code 446
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:55910-629-5210 in 1 CARTON06/03/2021
    11 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:55910-629-3930 in 1 CARTON06/09/202107/31/2025
    21 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA20253806/03/2021
    Labeler - Dolgencorp Inc (068331990)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!